Enavatuzumab (TNFRSF12A/CD266) - Research Grade Biosimilar antibody 10-447 from ProSci, Inc | Biocompare.com

Be the first to write a review!

Supplier Page from
ProSci, Inc for
Enavatuzumab (TNFRSF12A/CD266) - Research Grade Biosimilar antibody

The Enavatuzumab (TNFRSF12A/CD266) - Research Grade Biosimilar antibody from ProSci, Inc Monoclonal antibody.

Product Specs
ItemEnavatuzumab (TNFRSF12A/CD266) - Research Grade Biosimilar antibody
CompanyProSci, Inc
Price Pricing Info Supplier Page View Company Product Page
Catalog Number10-447
Antibody TypePrimary Antibodies
ClonalityRecombinant Monoclonal
ImmunogenHumanized / TNFRSF12A/CD266 [Homo sapiens]
Research AreaCancer
Conjugate/TagUnconjugated
Quantity0.1 mg
IsotypeIgG1 kappa
Concentrationbatch dependent
Purity>95%

Add to Compare List

ProSci, Inc

ProSci, Inc

ProSci Incorporated

12170 Flint Place

Poway, California 92064

United States

Phone: (888) 513-9525

(858) 513-2638
(858) 513-2692

Company Profile

Website: http://www.prosci-inc.com

Be the First to Write a Review!